The use of these inhibitors increased cellular expression of p53 and its target gene p21 (71), whilst further research using in vivo mouse xenograft models with androgen dependent LNCaP and androgen independent 22Rv1 cell lines, demonstrated increased apoptosis and reduced tumor burden in both cell types following Nutlins treatment (72, 73). Here, TP53 is linked to neoplasm.